Scinovex
article Open Access

Serum kreb von den lungen-6 (KL-6) as a useful biomarker for evaluation of Covid-19 disease severity

International Journal of Biology Sciences · 2024 · Vol. 6(1) · pp. 120–123

Abstract

Aim: The study aimed to investigate the role of KL-6 in severe and non severe Covid-19 patients. Method: In our study, 160 patients with Covid-19 were enrolled after being confirmed by RT-PCR. Estimation of KL-6, C-reactive protein (CRP) and lactate dehydrogenase (LDH) were performed, with comparing their levels in severe and non-severe cases. Study of the relationship between KL-6 and inflammatory marker was carried out by using the Spearman correlations. Results: The results showed an increase in CRP, LDH & Kl-6 levels in the sera of Covid-19 patients, and highly significant increases were observed in their levels in severe patients than in non-severe cases (p= 0.001, p= 0.000 & p= 0.000), respectively. Spearman’s correlation showed significant correlation between KL-6 & inflammation. Conclusion: It can be concluded that KL-6 seems to be a useful biomarker in the prognosis of Covid-19.

Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisPleural and Pulmonary DiseasesHematological disorders and diagnosticsCoronavirus disease 2019 (COVID-19)BiomarkerMedicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseInternal medicineVirologyBiologyInfectious disease (medical specialty)
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
3%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.